These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29491096)

  • 1. Associations Between Histogram Analysis DCE MRI Parameters and Complex
    Surov A; Leifels L; Meyer HJ; Winter K; Sabri O; Purz S
    Anticancer Res; 2018 Mar; 38(3):1637-1642. PubMed ID: 29491096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRI.
    Gawlitza M; Purz S; Kubiessa K; Boehm A; Barthel H; Kluge R; Kahn T; Sabri O; Stumpp P
    PLoS One; 2015; 10(8):e0134749. PubMed ID: 26270054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.
    Han M; Kim SY; Lee SJ; Choi JW
    Medicine (Baltimore); 2015 Nov; 94(47):e2141. PubMed ID: 26632740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
    Jansen JF; Schöder H; Lee NY; Stambuk HE; Wang Y; Fury MG; Patel SG; Pfister DG; Shah JP; Koutcher JA; Shukla-Dave A
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):299-307. PubMed ID: 21236594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
    An YS; Kang DK; Jung YS; Han S; Kim TH
    Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor vascularity and glucose metabolism correlated in adenocarcinoma, but not in squamous cell carcinoma of the lung.
    Zhang J; Chen L; Chen Y; Wang W; Cheng L; Zhou X; Wang J
    PLoS One; 2014; 9(3):e91649. PubMed ID: 24614132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma.
    Surov A; Stumpp P; Meyer HJ; Gawlitza M; Höhn AK; Boehm A; Sabri O; Kahn T; Purz S
    Oral Oncol; 2016 Jul; 58():14-20. PubMed ID: 27311397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
    Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
    Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
    Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.
    Kim TH; Yoon JK; Kang DK; Lee SJ; Jung YS; Yim H; An YS
    Ann Surg Oncol; 2015 Nov; 22(12):3866-72. PubMed ID: 25805237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.
    Jansen JF; Schöder H; Lee NY; Wang Y; Pfister DG; Fury MG; Stambuk HE; Humm JL; Koutcher JA; Shukla-Dave A
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1403-10. PubMed ID: 19906496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study.
    Subesinghe M; Scarsbrook AF; Sourbron S; Wilson DJ; McDermott G; Speight R; Roberts N; Carey B; Forrester R; Gopal SV; Sykes JR; Prestwich RJ
    BMC Cancer; 2015 Mar; 15():137. PubMed ID: 25885109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma.
    Choi JW; Lee D; Hyun SH; Han M; Kim JH; Lee SJ
    Clin Radiol; 2017 Jun; 72(6):482-489. PubMed ID: 28285707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ¹⁸F-FDG PET/CT and MRI in the follow-up of head and neck squamous cell carcinoma.
    Ghanooni R; Delpierre I; Magremanne M; Vervaet C; Dumarey N; Remmelink M; Lacroix S; Trotta N; Hassid S; Goldman S
    Contrast Media Mol Imaging; 2011; 6(4):260-6. PubMed ID: 21861286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined average standard uptake value and rate constant can predict expression of EGFR in hypopharyngeal squamous cell carcinoma: A pilot study with integrated PET/MRI.
    Zhang L; Meng Z; Huang C; Xian J
    Eur J Radiol; 2024 Mar; 172():111326. PubMed ID: 38280301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of metabolic parameters of (18)F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma.
    Min M; Lin P; Lee MT; Shon IH; Lin M; Forstner D; Bray V; Chicco A; Tieu MT; Fowler A
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1984-94. PubMed ID: 26081941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.